Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Benanserin hydrochloride
RN: 525-02-0
UNII: 86Q50C824Z
InChIKey: HEVSQLIUCMHBPN-UHFFFAOYSA-N

Classification Codes

  • Drug / Therapeutic Agent
  • Reproductive Effect

Molecular Formula

  • C19-H22-N2-O.Cl-H

Molecular Weight

  • 330.8567
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Benanserin hydrochloride

Synonyms

  • 1-Benzyl-2,5-dimethylserotonin hydrochloride
  • 1-Benzyl-2-methyl-3-(2-aminoethyl)-5-methoxyindole hydrochloride
  • 1-Benzyl-2-methyl-5-methoxytryptamine hydrochloride
  • 3-(2-Aminoethyl)-1-benzyl-5-methoxy-2-methylindole hydrochloride
  • 5-Methoxy-2-methyl-1-(phenylmethyl)-1H-indole-3-ethanamide monohydrochloride
  • BAS
  • Benanserin HCl
  • Benanserin hydrochloride
  • Benzyl antiserotonin
  • Benzyl-1 methyl-2 methoxy-5 tryptamine chlorhydrate
  • Benzyl-1 methyl-2 methoxy-5 tryptamine chlorhydrate [French]
  • NSC 17384
  • Serotonin benzyl analog
  • UNII-86Q50C824Z
  • Woolley's antiserotonin

Systematic Names

  • 1H-Indole-3-ethanamine, 5-methoxy-2-methyl-1-(phenylmethyl)-, monohydrochloride (9CI)
  • Indole, 3-(2-aminoethyl)-1-benzyl-5-methoxy-2-methyl-, monohydrochloride

Registry Numbers

CAS Registry Number

  • 525-02-0

FDA UNII

  • 86Q50C824Z

System Generated Number

  • 0000525020

Molecular Formulas

Molecular Formula

  • C19-H22-N2-O.Cl-H

Molecular Formula Fragments

  • C19-H22-N2-O
  • Cl-H
  • COMPONENT

Structure Descriptors

InChI

1S/C19H22N2O.ClH/c1-14-17(10-11-20)18-12-16(22-2)8-9-19(18)21(14)13-15-6-4-3-5-7-15;/h3-9,12H,10-11,13,20H2,1-2H3;1H

InChIKey

HEVSQLIUCMHBPN-UHFFFAOYSA-N

Smiles

Cc1c(c2cc(ccc2n1Cc3ccccc3)OC)CCN.Cl

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 250mg/kg (250mg/kg)   Journal of Medicinal Chemistry. Vol. 9, Pg. 819, 1966.
mouse LD50 subcutaneous 300mg/kg (300mg/kg)   Therapie. Vol. 18, Pg. 833, 1963.